I agree. The main thing to remember is that CBIS is ALL about the medicinal application of cannabis and its distribution through a cannabis specific pharmaceutical company. While the issue of full legalization may get the blood pumping, at the end of the day what is important is the clinical application of the medicine produced by CBIS. If you have faith in cannabis as a medicine, and it is not hard to considering there is in excess of 7000 peer reviewed scientific studies supporting this, then one must expect that it will be consumer demand that will drive this company.
Once patients find out that they no longer need to take opiate based, addictive medicines, for instance, the penny will begin to drop.
The fact of the matter is that cannabis has been used as a medicine for thousands of years and it has been carried through time by civilizations because of the FACT that it does work. Go figure.
Keep the faith guys. I am heading out to acquire more CBIS shares.
